Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-9957
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions? ; volume:8 ; number:1 ; day:23 ; month:8 ; year:2019 ; pages:1-4 ; date:12.2019
Infectious diseases of poverty ; 8, Heft 1 (23.8.2019), 1-4, 12.2019
- Urheber
-
Siewe Fodjo, Joseph Nelson
Kugler, Marina
Hotterbeekx, An
Hendy, Adam
Geertruyden, Jean-Pierre Van
Colebunders, Robert
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40249-019-0588-7
- URN
-
urn:nbn:de:101:1-2020010523142069384108
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Siewe Fodjo, Joseph Nelson
- Kugler, Marina
- Hotterbeekx, An
- Hendy, Adam
- Geertruyden, Jean-Pierre Van
- Colebunders, Robert
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin
Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis
High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
Onchocerciasis
Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin
Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis
High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
Onchocerciasis
Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin
Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis
High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
Onchocerciasis
Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria